ABT - Abbott Laboratories

NYSE - NYSE Delayed price. Currency in USD
Currency in USD

Valuation measures4

Market cap (intra-day) 176.83B
Enterprise value 184.20B
Trailing P/E 30.90
Forward P/E 23.09
PEG ratio (5-yr expected) 10.50
Price/sales (ttm)4.31
Price/book (mrq)4.78
Enterprise value/revenue 4.44
Enterprise value/EBITDA 17.02

Trading information

Stock price history

Beta (5Y monthly) 0.66
52-week change 3-3.98%
S&P500 52-week change 314.65%
52-week high 3115.69
52-week low 393.25
50-day moving average 3106.43
200-day moving average 3104.86

Share statistics

Avg vol (3-month) 35.13M
Avg vol (10-day) 35.1M
Shares outstanding 51.74B
Implied shares outstanding 6N/A
Float 81.73B
% held by insiders 10.55%
% held by institutions 176.06%
Shares short (14 May 2023) 412.95M
Short ratio (14 May 2023) 42.63
Short % of float (14 May 2023) 40.75%
Short % of shares outstanding (14 May 2023) 40.74%
Shares short (prior month 13 Apr 2023) 412.6M

Dividends & splits

Forward annual dividend rate 42.04
Forward annual dividend yield 42.01%
Trailing annual dividend rate 31.96
Trailing annual dividend yield 31.94%
5-year average dividend yield 41.54
Payout ratio 458.36%
Dividend date 314 May 2023
Ex-dividend date 412 Apr 2023
Last split factor 210000:4798
Last split date 301 Jan 2013

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2022
Most-recent quarter (mrq)30 Mar 2023


Profit margin 13.98%
Operating margin (ttm)18.00%

Management effectiveness

Return on assets (ttm)6.32%
Return on equity (ttm)15.93%

Income statement

Revenue (ttm)41.51B
Revenue per share (ttm)23.75
Quarterly revenue growth (yoy)-18.10%
Gross profit (ttm)24.58B
Net income avi to common (ttm)5.78B
Diluted EPS (ttm)3.27
Quarterly earnings growth (yoy)-46.10%

Balance sheet

Total cash (mrq)9.53B
Total cash per share (mrq)5.48
Total debt (mrq)17.03B
Total debt/equity (mrq)45.73
Current ratio (mrq)1.68
Book value per share (mrq)21.28

Cash flow statement

Operating cash flow (ttm)8.66B
Levered free cash flow (ttm)6.41B